tasimelteon 4 MG/ML Oral Suspension [Hetlioz]
RxNorm concept 2468316, branded drug (sbd). Prescribable name: Hetlioz LQ 4 MG/mL Oral Suspension.
- RxCUI
- 2468316
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2468316 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Hetlioz 4 MG/ML Oral Suspension; Hetlioz LQ 4 MG/ML Oral Suspension
Related concepts
- tasimelteon 4 MG/ML (SCDC, consists of)
- tasimelteon 4 MG/ML [Hetlioz] (SBDC, consists of)
- Oral Suspension (DF, has dose form)
- Hetlioz (BN, has ingredient)
- tasimelteon 4 MG/ML Oral Suspension (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2468316 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2468316 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2468316. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.